|Abstract||This guideline offers recommendations on the diagnostic tests, treatment regimens and health promotion principles needed for the effective management of C.trachomatis. It covers management of the initial presentation, as well as how to prevent transmission and future infection.|
It is aimed primarily at people aged 16 years or older (see specific guidelines for those under 16) presenting to health care professionals, working in departments offering level 3 care in STI management (see national strategy) within the United Kingdom. However, the principles of the recommendations should be adopted across all levels (levels 1 and 2 may need to develop, where appropriate, local care pathways).
This guideline has been produced by medical specialists from relevant disciplines with input from patients attending UK GUM clinics. Successive drafts have been reviewed by GUM patients, GUM physicians, nurses, health advisers and key professional organisations.
An extensive literature reviewed was carried out using Medline searches for the years 1970 to 2001 using keywords “Chlamydia trachomatis” in association with "polymerase chain reaction” or “PCR” or “ligase chain reaction” or “lcr” or “lcx” and “immunoenzyme techniques” or “enzyme-linked immunosorbent assay”. “Chlamydia trachomatis” combined with the following key words “detection”, “diagnosis”, “treatment”. The Cochrane library: “Chlamydia trachomatis”. This literature search was updated in 2005 and included nucleic acid amplification technique, Aptima, Probetec and SDA.